1,956
Views
1
CrossRef citations to date
0
Altmetric
Articles

Feasibility of assessing male osteoporosis using MRI IDEAL-IQ sequence of proximal femur in prostate cancer patients

ORCID Icon, ORCID Icon, , , , , & show all
Pages 228-233 | Received 29 Jun 2022, Accepted 09 Aug 2022, Published online: 23 Aug 2022

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.
  • Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, et al. The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate Int. 2015;3(4):135–140.
  • Manolagas SC, O'Brien CA, Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013;9(12):699–712.
  • Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301(5):513–521.
  • Tanvetyanon T. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy. Cancer. 2005;103(2):237–241.
  • Alibhai SM, Yun L, Cheung AM, et al. Screening for osteoporosis in men receiving androgen deprivation therapy. JAMA. 2012;307(3):255–256.
  • Imajo K, Kessoku T, Honda Y, et al. MRI-Based quantitative R2(*) mapping at 3 tesla reflects hepatic iron overload and pathogenesis in nonalcoholic fatty liver disease patients. Magnetic Resonance Imaging. 2022;55(1):111–125.
  • Eskreis-Winkler S, Corrias G, Monti S, et al. IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron. Cancer Imaging. 2018;18(1):51.
  • Ma Q, Cheng X, Hou X, et al. Bone marrow fat measured by a chemical Shift-Encoded sequence (IDEAL-IQ) in patients with and without metabolic syndrome. J Magn Reson Imaging. 2021;54(1):146–153.
  • Zeng Z, Ma X, Guo Y, et al. Quantifying bone marrow fat fraction and iron by MRI for distinguishing aplastic anemia from myelodysplastic syndromes. J Magn Reson Imaging. 2021;54(6):1754–1760.
  • Chandran M, Mitchell PJ, Amphansap T, et al. Development of the Asia pacific consortium on osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region. Osteoporos Int. 2021;32(7):1249–1275.
  • Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733.
  • Walsh JS, Eastell R. Osteoporosis in men. Nat Rev Endocrinol. 2013;9(11):637–645.
  • Nielson CM, Marshall LM, Adams AL, et al. BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J Bone Miner Res. 2011;26(3):496–502.
  • Fazeli PK, Horowitz MC, MacDougald OA, et al. Marrow fat and bone-new perspectives. J Clin Endocrinol Metab. 2013;98(3):935–945.
  • Schwartz AV. Marrow fat and bone: review of clinical findings. Front Endocrinol (Lausanne). 2015;6:40.
  • Yu B, Huo L, Liu Y, et al. PGC-1alpha controls skeletal stem cell fate and Bone-Fat balance in osteoporosis and skeletal aging by inducing TAZ. Cell Stem Cell. 2018;23(4):615–623.
  • Schwartz AV, Sigurdsson S, Hue TF, et al. Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults. J Clin Endocrinol Metab. 2013;98(6):2294–2300.
  • Wocial K, Feldman BA, Mruk B, et al. Imaging features of the aging spine. Pol J Radiol. 2021;86:e380–e386.
  • Griffith JF, Yeung DK, Antonio GE, et al. Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology. 2005;236(3):945–951.
  • Watanabe D, Kimura T, Yamashita A, et al. The influence of androgen deprivation therapy on hip geometric properties and bone mineral density in Japanese men with prostate cancer and its relationship with the visceral fat accumulation. Aging Male. 2020;23(5):1158–1164.
  • Futterer JJ, Briganti A, De Visschere P, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 2015;68(6):1045–1053.